Retinoblastoma is a rare type of eye cancer that starts in the retina, the light-sensitive tissue at the back of the eye. It most often affects young children. It's a serious condition that needs prompt medical attention.
Every report comes from a Lived member, sent anonymously.
Have you had Eye Enucleation for Retinoblastoma?
Retinoblastoma is a cancer that starts in the retina, the thin layer of light-sensing tissue at the back of the eye that sends visual signals to the brain. It is the most common eye cancer in children and almost always affects the very young: about two out of three cases are found before age 2, and nearly all before age 5. It is rare, with roughly 300 to 350 children diagnosed in the United States each year. The tumor can affect one eye or both. The sign parents most often notice is a pupil that looks white instead of the usual red when light shines into it, which often shows up first in a flash photograph. Eyes that look in different directions (crossed or misaligned eyes) are the next most common sign. Retinoblastoma matters because it threatens both sight and life if it spreads beyond the eye, but when it is found while still inside the eye, it is usually curable.
Retinoblastoma develops when a gene called RB1, which normally keeps cell growth in check, is changed in a developing retinal cell, allowing that cell to multiply into a tumor. There are two forms, and the difference shapes much of a family's care. In the heritable form, the RB1 change is present in every cell of the child's body. Estimates of how common this is range from about a quarter to 4 in 10 children with retinoblastoma. It is more likely when both eyes are affected, when there are several tumors or when another relative had retinoblastoma. Only about 1 in 4 children with the heritable form has a family history, because the change often arises for the first time in that child. A person with heritable retinoblastoma has a 1 in 2 chance of passing the RB1 change to each child, and most children who inherit it develop the tumor. In the nonheritable form, which is more common, the RB1 changes happen by chance in the eye alone. It usually affects one eye and is not passed on. There are no known avoidable causes, and nothing a parent did or failed to do during pregnancy is known to cause retinoblastoma.
Retinoblastoma is usually first suspected during a red reflex check, a quick test in which a clinician shines a light into a baby's eyes and looks for a matching red glow. In the United States it is recommended within the first 2 months of life and at later well-child visits. A dim, uneven or white reflex needs evaluation by an ophthalmologist (an eye doctor). The diagnosis is made by a specialist who examines the retina closely through a dilated pupil. In young children this exam is often done under anesthesia so the whole retina can be mapped. Ultrasound of the eye and magnetic resonance imaging (MRI) show the tumor's size and whether it has grown toward the optic nerve or beyond the eye; MRI is preferred over computed tomography (CT) scans because it does not use radiation. Unlike most cancers, retinoblastoma is usually diagnosed without a biopsy, because cutting into the eye risks spreading the tumor. Genetic testing of blood, and of tumor tissue when available, looks for an RB1 change. The result tells the family whether the child has the heritable form, which affects how closely the other eye and the brain are watched and what siblings and future children may need.
Treatment is planned by a team experienced in childhood eye cancer, led by a pediatric oncologist and an eye specialist. The goals come in order: save the child's life, then save the eye and as much vision as possible, while limiting long-term side effects. The plan depends on the size and number of tumors, whether one or both eyes are involved and whether the cancer has spread. When the eye can likely be saved, chemotherapy is usually used first to shrink the tumor. It can be given through a vein so it reaches the whole body, or delivered straight to the eye through a thin tube threaded into the eye's main artery (ophthalmic artery chemotherapy, offered at specialized centers). Drugs may also be injected into the gel inside the eye when tumor cells have seeded there. Smaller tumors are then treated directly with a laser that heats them (thermotherapy) or a probe that freezes them (cryotherapy). Radiation, either a small radioactive plaque stitched temporarily to the eye or external beams, is reserved for some situations because it raises the risk of later cancers, particularly in babies and children with the heritable form. When a tumor is large and there is little chance of useful vision, removing the eye (enucleation) is often the safest choice. The child is later fitted with an artificial eye. If cancer has spread beyond the eye, treatment becomes more intensive, often combining chemotherapy, radiation and sometimes high-dose chemotherapy with a stem cell transplant. Clinical trials are an important option for this rare cancer.
In the United States, more than 95 out of 100 children with retinoblastoma are alive 5 years after diagnosis, and most are cured. The biggest factor in outlook is whether the cancer has spread outside the eye. That is uncommon in the United States but much more common where diagnosis comes late. Once it reaches the brain or the fluid around it, survival is low even with intense treatment. Vision depends on how much of the retina the tumor damaged, especially the central part used for detailed sight. When only one eye is affected, the other eye usually provides useful sight. Treatment can bring side effects during therapy and some longer-term effects, such as vision or hearing problems, changes in the growth of the bone around a removed eye in very young children, or effects on learning. Follow-up is long and frequent. New tumors can appear for a few years after treatment in children with the heritable form, so eye exams, often under anesthesia, are usually done every 2 to 4 months for at least 28 months, and the other eye is watched until the nonheritable form is confirmed. Children with the heritable form may also have brain MRI scans for several years, because of a small risk of a related tumor in the pineal gland, a structure in the center of the brain. Their risk of other cancers later in life, such as bone and soft tissue sarcomas, melanoma, and lung or bladder cancer, stays raised for life and is higher after radiation. That makes survivorship care with clinicians familiar with these late effects an ongoing part of life, including into adulthood.
Contact your child's doctor promptly, rather than waiting for the next checkup, if a pupil looks white instead of red in light or in flash photos, or if the eyes look crossed or point in different directions. Ask for timely referral to an ophthalmologist if an abnormal red reflex is found. Eye pain or redness, swelling around the eye, an eye that looks larger than the other or a cloudy colored part of the eye also need a prompt visit. These signs are more often caused by something else, but retinoblastoma is far easier to treat when found early. If a parent, brother or sister had retinoblastoma, arrange a specialist eye exam soon after birth and genetic counseling, ideally before the baby is born, since RB1 testing can be done during pregnancy or soon after birth. Regular exams continue through early childhood unless testing shows the baby did not inherit the RB1 change. After treatment, report any new change in how an eye looks to the care team between scheduled exams.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Retinoblastoma is like, what's helped you, or ask the community a question.